DAP3 and colorectal carcinoma: Knockdown of DAP3 and DELE1, respectively, in colon cancer CRC cell lines sensitized the cells to 5-FU, Methotrexate, and Docetaxel, and cells with simultaneous knockdown of DAP3 and DELE1 were markedly sensitive to all the drugs tested, compared with the single knockdown lines and the controls.